Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on Cigna Group CI in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 6 | 3 | 0 | 0 |
| Last 30D | 0 | 2 | 0 | 0 | 0 |
| 1M Ago | 1 | 2 | 1 | 0 | 0 |
| 2M Ago | 1 | 2 | 1 | 0 | 0 |
| 3M Ago | 1 | 0 | 1 | 0 | 0 |
Analysts have recently evaluated Cigna Group and provided 12-month price targets. The average target is $361.67, accompanied by a high estimate of $392.00 and a low estimate of $334.00. Surpassing the previous average price target of $347.25, the current average has increased by 4.15%.
Breaking Down Analyst Ratings: A Detailed Examination
The standing of Cigna Group among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Erin Wright | Morgan Stanley | Raises | Overweight | $392.00 | $382.00 |
| Sarah James | Cantor Fitzgerald | Maintains | Overweight | $372.00 | - |
| Stephen Baxter | Wells Fargo | Raises | Equal-Weight | $348.00 | $334.00 |
| Ann Hynes | Mizuho | Raises | Buy | $370.00 | $360.00 |
| Sarah James | Cantor Fitzgerald | Raises | Overweight | $372.00 | $334.00 |
| Frank Morgan | RBC Capital | Raises | Outperform | $354.00 | $327.00 |
| George Hill | Deutsche Bank | Raises | Buy | $370.00 | $355.00 |
| Sarah James | Cantor Fitzgerald | Maintains | Neutral | $334.00 | - |
| Michael Wiederhorn | Oppenheimer | Maintains | Outperform | $360.00 | - |
| Lance Wilkes | Bernstein | Announces | Outperform | $372.00 | - |
| George Hill | Deutsche Bank | Raises | Hold | $355.00 | $351.00 |
| David Windley | Jefferies | Raises | Buy | $341.00 | $335.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cigna Group. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Cigna Group compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Cigna Group's stock. This comparison reveals trends in analysts' expectations over time.
For valuable insights into Cigna Group's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Cigna Group analyst ratings.
About Cigna Group
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 18 million U.S. medical members covered as of the end of June 2023.
Key Indicators: Cigna Group's Financial Health
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Over the 3 months period, Cigna Group showcased positive performance, achieving a revenue growth rate of 8.46% as of 30 September, 2023. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Cigna Group's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 2.87%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Cigna Group's ROE stands out, surpassing industry averages. With an impressive ROE of 3.09%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Cigna Group's ROA excels beyond industry benchmarks, reaching 0.94%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.68, Cigna Group adopts a prudent financial strategy, indicating a balanced approach to debt management.
Analyst Ratings: What Are They?
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
